These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4298464)

  • 41. Intrasplenic angiotensin--a simple test for the diagnosis of porto-systemic venous anastomosis.
    Bisht DB; Dasgupta D
    Indian Heart J; 1970 Jan; 22(1):57-60. PubMed ID: 4321910
    [No Abstract]   [Full Text] [Related]  

  • 42. [Renin and aldosterone in human arterial hypertension (excluding Conn's syndrome)].
    Veyrat R; Genest J; Tremblay G; Boucher R; de Champlain J
    Pathol Biol; 1965 Nov; 13(21):1086-93. PubMed ID: 4299263
    [No Abstract]   [Full Text] [Related]  

  • 43. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
    Williams GH; Hollenberg NK
    J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The use of radioimmunoassay of angiotensin I and angiotensin II in the diagnostics of renovascular hypertension].
    Ripka O; Ort J; Linhartová J; Tvrzická E; Reinisová J
    Cesk Radiol; 1972 Jul; 26(4):223-4. PubMed ID: 4339177
    [No Abstract]   [Full Text] [Related]  

  • 45. Suppressed plasma renin activity in hypertension.
    Channick BJ; Adlin EV; Marks AD
    Arch Intern Med; 1969 Feb; 123(2):131-40. PubMed ID: 4303266
    [No Abstract]   [Full Text] [Related]  

  • 46. [Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension].
    Kabat M; Makowiecka-Cieśla M
    Kardiol Pol; 1984; 27(2):147-57. PubMed ID: 6328092
    [No Abstract]   [Full Text] [Related]  

  • 47. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP; Philipp T
    Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672
    [No Abstract]   [Full Text] [Related]  

  • 48. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F; Messore T; Catzola A; Corvino A; Genovese A; Catalano M; Mercone G
    Recenti Prog Med; 1983 Apr; 74(4):415-29. PubMed ID: 6348901
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients.
    Sanchez-Ramos L; Briones DK; Kaunitz AM; Delvalle GO; Gaudier FL; Walker CD
    Obstet Gynecol; 1994 Sep; 84(3):349-53. PubMed ID: 8058229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of saralasin as a diagnostic test in hypertension. Report of a Consensus Committee.
    Arch Intern Med; 1982 Aug; 142(8):1437-40. PubMed ID: 7049102
    [No Abstract]   [Full Text] [Related]  

  • 52. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Renin-angiotensin system in hypertension].
    Fyhrquist F
    Duodecim; 1974; 90(9):666-75. PubMed ID: 4371118
    [No Abstract]   [Full Text] [Related]  

  • 54. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
    Erley CM; Grau C; Furian TC; Wolf S; Braun N; Risler T
    Clin Nephrol; 1996 Nov; 46(5):312-8. PubMed ID: 8953120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Early diagnosis and treatment of hypertension and renal vascular hypertension].
    Murakami M; Morimoto S; Kuroda M
    Naika; 1969 Jun; 23(6):1124-36. PubMed ID: 4308745
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.
    Zimmerman MC; Lazartigues E; Sharma RV; Davisson RL
    Circ Res; 2004 Jul; 95(2):210-6. PubMed ID: 15192025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Skin reaction of healthy pregnant women and women with late toxemia to angiotensin II].
    Balák K; Vedra B
    Cesk Gynekol; 1968 Dec; 33(10):725-8. PubMed ID: 4303623
    [No Abstract]   [Full Text] [Related]  

  • 58. [Significance of determination of renin-angiotensin system in hypertension].
    Arakawa K; Miohara A; Yamada J; Uemura N
    Naika; 1969 Oct; 24(4):610-5. PubMed ID: 4311626
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [On the angiotensin resistance of non-hypertensive types of chronic pyelonephritis].
    Commichau R; Koch HG; Hoya HC
    Klin Wochenschr; 1968 Apr; 46(7):370-4. PubMed ID: 4301055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.